Čájehuvvojit 1 - 3 oktiibuot 3 bohtosis ohcui Anne S.R. van Lindert', ohcanáigi: 0,02s Aiddostahte ozu
  1. 1
    Acute-Onset Pneumonitis while Administering the First Dose of Durvalumab

    Acute-Onset Pneumonitis while Administering the First Dose of Durvalumab Dahkki Erwin H.J. Tonk, Anne S.R. van Lindert, Joost J.C. Verhoeff, Karijn P.M. Suijkerbuijk

    Almmustuhtton 2019-08-01
    Viečča ollesdeavstta
    Artihkal
  2. 2
    Individual treatment effect estimation in the presence of unobserved confounding using proxies: a cohort study in stage III non-small cell lung cancer

    Individual treatment effect estimation in the presence of unobserved confounding using proxies: a cohort study in stage III non-small cell lung cancer Dahkki Wouter A. C. van Amsterdam, Joost. J. C. Verhoeff, Netanja I. Harlianto, Gijs A. Bartholomeus, Aahlad Manas Puli, Pim A. de Jong, Tim Leiner, Anne S. R. van Lindert, Marinus J. C. Eijkemans, Rajesh Ranganath

    Almmustuhtton 2022-04-01
    Viečča ollesdeavstta
    Artihkal
  3. 3
    The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients

    The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients Dahkki Corine deJong, Najiba Chargi, Gerarda J.M. Herder, Simone W.A. vanHaarlem, Femke van derMeer, Anne S.R. vanLindert, Alexandra tenHeuvel, Jan Brouwer, Pim A. deJong, Lot A. Devriese, Alwin D.R. Huitema, Toine C.G. Egberts, Remco deBree, Vera H.M. Deneer

    Almmustuhtton 2022-06-01
    Viečča ollesdeavstta
    Artihkal

Ohcanreaiddut: